These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8318321)
41. Morphine Use in Renal Failure: A Case Report of Single-Dose Morphine Toxicity in a Patient Requiring Peritoneal Dialysis. Slater NA; Todd AM; Trimmier MC; Campbell KC J Pharm Pract; 2020 Dec; 33(6):903-906. PubMed ID: 31248317 [TBL] [Abstract][Full Text] [Related]
42. Sufentanil disposition in patients undergoing renal transplantation: influence of choice of kinetic model. Sear JW Br J Anaesth; 1989 Jul; 63(1):60-7. PubMed ID: 2569886 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure. MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968 [TBL] [Abstract][Full Text] [Related]
44. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Klimas R; Mikus G Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077 [TBL] [Abstract][Full Text] [Related]
45. Erythrocyte glucose-6-phosphate dehydrogenase in chronic renal failure and after renal transplantation. Milman N Scand J Haematol; 1980 Apr; 24(4):307-14. PubMed ID: 6997987 [TBL] [Abstract][Full Text] [Related]
46. Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney. Van Crugten JT; Sallustio BC; Nation RL; Somogyi AA Drug Metab Dispos; 1991; 19(6):1087-92. PubMed ID: 1687015 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers. Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362 [TBL] [Abstract][Full Text] [Related]
48. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients. Ashby M; Fleming B; Wood M; Somogyi A J Pain Symptom Manage; 1997 Sep; 14(3):157-67. PubMed ID: 9291702 [TBL] [Abstract][Full Text] [Related]
49. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis. Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835 [TBL] [Abstract][Full Text] [Related]
50. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney. Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298 [TBL] [Abstract][Full Text] [Related]
51. Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis. Whelton A; Stout RL; Delgado FA J Antimicrob Chemother; 1983 May; 11 Suppl B():89-95. PubMed ID: 6619036 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment. Flor S; Guay D; Opsahl J; Tack K; Matzke G Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697 [TBL] [Abstract][Full Text] [Related]
53. [Plasma pharmacokinetics of morphine and morphine-6-glucuronide using high performance liquid chromatography and colorimetric detection]. Barberi-Heyob M; Merlin JL; Krakowski I; Kettani C; Collin E; Poulain P Bull Cancer; 1991 Nov; 78(11):1063-70. PubMed ID: 1369552 [TBL] [Abstract][Full Text] [Related]
54. High levels of morphine-6-glucuronide in street heroin addicts. Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191 [TBL] [Abstract][Full Text] [Related]
55. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study. Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002 [TBL] [Abstract][Full Text] [Related]
56. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. Frances B; Gout R; Monsarrat B; Cros J; Zajac JM J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685 [TBL] [Abstract][Full Text] [Related]